Structural development of liver X receptor (LXR) antagonists derived from thalidomide-related glucosidase inhibitors
T Noguchi-Yachide, H Miyachi, H Aoyama…
Index: Noguchi-Yachide, Tomomi; Miyachi, Hiroyuki; Aoyama, Hiroshi; Aoyama, Atsushi; Makishima, Makoto; Hashimoto, Yuichi Chemical and Pharmaceutical Bulletin, 2007 , vol. 55, # 12 p. 1750 - 1754
Full Text: HTML
Citation Number: 17
Abstract
Following our previous discovery of LXR antagonistic activity of 2′-substituted phenylphthalimides derived from thalidomide-related glucosidase inhibitors, structure– activity studies and further structural development led to 5-chloro-N-2′-n-pentylphenyl-1, 3- dithiophthalimide (5CPPSS-50), with IC 50 values of about 10 and 13 μM for LXRα and LXRβ, respectively.
Related Articles:
[Dalmolen, Jan; Van Der Sluis, Marcel; Nieuwenhuijzen, Jose W.; Meetsma, Auke; De Lange, Ben; Kaptein, Bernard; Kellogg, Richard M.; Broxterman, Quirinus B. European Journal of Organic Chemistry, 2004 , # 7 p. 1544 - 1557]
[Dalmolen, Jan; Van Der Sluis, Marcel; Nieuwenhuijzen, Jose W.; Meetsma, Auke; De Lange, Ben; Kaptein, Bernard; Kellogg, Richard M.; Broxterman, Quirinus B. European Journal of Organic Chemistry, 2004 , # 7 p. 1544 - 1557]
[Dalmolen, Jan; Van Der Sluis, Marcel; Nieuwenhuijzen, Jose W.; Meetsma, Auke; De Lange, Ben; Kaptein, Bernard; Kellogg, Richard M.; Broxterman, Quirinus B. European Journal of Organic Chemistry, 2004 , # 7 p. 1544 - 1557]